Picard Medical, Inc. Cash Flow Conversion Efficiency
Picard Medical, Inc. cash flow conversion efficiency. Based on the latest financial reports, Picard Medical, Inc. (PMI) has a cash flow conversion efficiency ratio of -1.155x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.38 Million) by net assets ($3.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Picard Medical, Inc. (2022–2025)
Cash flow conversion efficiency of Picard Medical, Inc. from 2022 to 2025. This chart illustrates how Picard Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View PMI live share price for real-time trading data and today's change.
Picard Medical, Inc. Cash Flow Conversion Ratio Explained
Picard Medical, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Picard Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Picard Medical, Inc. ranked by their cash flow conversion efficiency. Also see market value of Picard Medical, Inc. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Auking Mining Ltd
AU:AKN
|
-0.199x |
|
123fahrschule SE
DU:123F
|
-0.004x |
|
Toleranzia AB
ST:TOL
|
-0.023x |
|
Vaswani Industries Limited
NSE:VASWANI
|
0.072x |
|
Vertice Bhd
KLSE:7240
|
0.051x |
|
Bionano Genomics Inc
NASDAQ:BNGO
|
-0.148x |
|
Schulte-Schlagbaum AG
DU:SSS
|
N/A |
|
Soditech SA
PA:SEC
|
0.053x |
Annual Cash Flow Conversion Efficiency for Picard Medical, Inc. (2022–2025)
The table below shows the annual cash flow conversion efficiency of Picard Medical, Inc. from 2022 to 2025. Review how financially flexible is Picard Medical, Inc. to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.79 Million | $-15.67 Million | -4.136x | -926.87% |
| 2024-12-31 | $-23.74 Million | $-11.87 Million | 0.500x | -83.29% |
| 2023-12-31 | $-3.55 Million | $-10.63 Million | 2.994x | +417.42% |
| 2022-12-31 | $11.37 Million | $-10.72 Million | -0.943x | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more